Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Rapid Communications
Survey of Palliative Sedation at End of Life in Terminally Ill Heart Failure Patients ― A Single-Center Experience of 5-Year Follow-up ―
Yasuhiro HamataniEri NakaiEmi NakamuraMichi MiyataYukie KawanoYasuko TakadaYuta AnchiSayaka FunabashiAtsushi HirayamaKensuke KurodaMasashi AmanoYasuo SuganoToshihisa AnzaiChisato Izumi
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2019 Volume 83 Issue 7 Pages 1607-1611

Details
Abstract

Background:Little is known about palliative sedation in terminally ill heart failure (HF) patients.

Methods and Results:We retrospectively reviewed terminally ill HF patients who received palliative sedation from September 2013 to August 2018. Among 95 terminally ill HF patients, 25 were prescribed dexmedetomidine and 12 were prescribed midazolam at the end of life. Richmond Agitation-Sedation Scale was significantly reduced (P<0.01), but blood pressure and heart rate were unaltered after treatment in both the dexmedetomidine and midazolam groups.

Conclusions:Prescription of dexmedetomidine and/or midazolam might be feasible in selected terminally ill HF patients.

Content from these authors
© 2019 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top